Rezaeejam, Hamed

Magnetite and bismuth sulfide Janus heterostructures as radiosensitizers for in vivo enhanced radiotherapy in breast cancer

Nosrati, H., Ghaffarlou, M., Salehiabar, M., Mousazadeh, N., Abhari, F., Barsbay, M., Ertas, Y. N., Rashidzadeh, H., Mohammadi, A., Nasehi, L., et al. (2022) · Biomaterials Advances

Radiation Therapy and DosimetryNanoplatforms for cancer theranostics

Cited by 60

Iron oxide and gold bimetallic radiosensitizers for synchronous tumor chemoradiation therapy in 4T1 breast cancer murine model

Nosrati, H., Baghdadchi, Y., Abbasi, R., Barsbay, M., Ghaffarlou, M., Abhari, F., Mohammadi, A., Kavetskyy, T., Bochani, S., Rezaeejam, H., et al. (2021) · Journal of Materials Chemistry B

Radiation Therapy and DosimetryNanoplatforms for cancer theranostics

Cited by 37

Zinc nanoparticles coated with doxorubicin-conjugated alginate as a radiation sensitizer in triple-negative breast cancer cells

Asadi, N., Gharbavi, M., Rezaeejam, H., Farajollahi, A., & Johari, B. (2024) · International Journal of Pharmaceutics

Radiation Therapy and DosimetryNanoparticle-Based Drug Delivery

Cited by 23

Facile preparation of silver based radiosensitizers via biomineralization method for enhanced in vivo breast cancer radiotherapy

Ghaffarlou, M., Mohammadi, A., Mousazadeh, N., Salehiabar, M., Kalantari, Y., Charmi, J., Barsbay, M., Ertas, Y. N., Danafar, H., Rezaeejam, H., et al. (2023) · Scientific Reports

Radiation Therapy and DosimetryNanoplatforms for cancer theranostics

Cited by 20

A multifunctional curcumin–Fe 3 O 4 @ZIF-8 nanoformulation as a T 2 MRI contrast agent and pH-responsive theranostic platform for targeted ROS generation, radiosensitization, and triple-negative breast cancer treatment

Rahmani, A., Maleki, A., Jafari, R., Rezaeejam, H., & Nadri, S. (2025) · Journal of Materials Chemistry B

Nanoplatforms for cancer theranosticsNanoparticle-Based Drug Delivery

Cited by 10